{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:27Z","timestamp":1759336347535,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.jneuroim.2008.08.013","type":"journal-article","created":{"date-parts":[[2008,10,6]],"date-time":"2008-10-06T04:24:48Z","timestamp":1223267088000},"page":"110-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Susceptibility to Guillain\u2013Barr\u00e9 syndrome is not associated with CD1A and CD1E gene polymorphisms"],"prefix":"10.1016","volume":"205","author":[{"given":"Mark L.","family":"Kuijf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Geleijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noureddine","family":"Ennaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"van Rijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter A.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.08.013_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.08.013_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jneuroim.2007.03.004","article-title":"A letter to the editor in reply to \u201csusceptibility to Guillain-Barr\u00e9 syndrome is associated to polymorphisms of CD1 genes\u201d by Caporale et al. in the J of Neuroimmunology (2006), 177:112\u2013118","volume":"186","author":"Bang","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.08.013_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2006.05.018","article-title":"Susceptibility to Guillain-Barr\u00e9 syndrome is associated to polymorphisms of CD1 genes","volume":"177","author":"Caporale","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.08.013_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jneuroim.2007.11.015","article-title":"Susceptibility to Guillain-Barr\u00e9 syndrome is associated to polymorphisms of CD1 genes\u201d by Bang et al. in the J of Neuroimmunology (2007). 186, 201\u2013202","volume":"194","author":"Caporale","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.08.013_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/447655a","article-title":"Replicating genotype\u2013phenotype associations","volume":"447","author":"Chanock","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2008.08.013_bib6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1126\/science.1115301","article-title":"Assistance of microbial glycolipid antigen processing by CD1e","volume":"310","author":"de la Salle","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2008.08.013_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.immuni.2005.04.013","article-title":"Bacterial infections promote T cell recognition of self-glycolipids","volume":"22","author":"De Libero","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2008.08.013_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jnnp.2004.046227","article-title":"Amantadine for treatment of fatigue in Guillain-Barr\u00e9 syndrome: a randomised, double blind, placebo controlled, crossover trial","volume":"77","author":"Garssen","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.08.013_bib9","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/jnnp.2006.102731","article-title":"Treatment of Guillain-Barr\u00e9 syndrome with mycophenolate mofetil: a pilot study","volume":"78","author":"Garssen","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.08.013_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jneuroim.2004.01.003","article-title":"Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barr\u00e9 patients","volume":"150","author":"Geleijns","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.08.013_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/01.WNL.0000148727.02732.01","article-title":"HLA class II alleles are not a general susceptibility factor in Guillain-Barr\u00e9 syndrome","volume":"64","author":"Geleijns","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.08.013_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1034\/j.1399-0039.1999.540202.x","article-title":"Polymorphism of human CD1 genes","volume":"54","author":"Han","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2008.08.013_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1017\/S0950268800004933","article-title":"Health burden in the Netherlands due to infection with thermophilic Campylobacter spp.","volume":"125","author":"Havelaar","year":"2000","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.jneuroim.2008.08.013_bib14","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0198-8859(01)00314-7","article-title":"Structural characterization of two CD1A allelic variants","volume":"62","author":"Oteo","year":"2001","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2008.08.013_bib15","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.4049\/jimmunol.180.6.3642","article-title":"Cutting edge: a naturally occurring mutation in CD1e impairs lipid antigen presentation","volume":"180","author":"Tourne","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.08.013_bib16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"van der Mech\u00e9","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2008.08.013_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","article-title":"Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome: randomised trial","volume":"363","author":"van Koningsveld","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.08.013_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1085-9489.2005.0010202.x","article-title":"The immunobiology of Guillain-Barr\u00e9 syndromes","volume":"10","author":"Willison","year":"2005","journal-title":"J. Peripher. Nerv. Syst."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808003883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808003883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:10:11Z","timestamp":1759047011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572808003883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":18,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0165572808003883"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.08.013","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibility to Guillain\u2013Barr\u00e9 syndrome is not associated with CD1A and CD1E gene polymorphisms","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}